Digital devices and clinical trials J
Five issues confront digital devices moving into clinical practice: usability, accuracy, safety, convenience, ease of [MORE]
Stem Cells for Cosmetic Surgery
Regenerative medicine holds many wonders, but not without worries too. This piece tells how plastic surgeons [MORE]
In a new handbook that guides innovators through a process from discovery to the marketplace, Richard J. McMurtrey, M. [MORE]
Over the next five years, the National Institutes of Health, the Defense Advanced Research Projects Agency (DARPA) and the [MORE]
Tagline rarely includes news about drugs, much less nutritional supplements, but this piece-an FDA warning about Magic Power Coffee, [MORE]
The infusion pump is a ubiquitous piece of hospital equipment, often at a 3:1 ratio to the number of [MORE]
The FDA recently issued guidelines for using Bayesian statistical methods to correlate data from current and earlier clinical trials [MORE]
There aren’t many, if any, better sources of information about medical devices than the FDA’s website “Device Advice.” It gives [MORE]
Several bills now in Congress could result in a fundamental change to patenting biologics (such as monoclonal antibodies). One bill [MORE]
The FDA has approved GTC Biotherapeutics’ (Framingham, MA) antithrombin alpha from genetically engineered goats. For more than a decade, recombinant [MORE]
The Obama administration likely will have the FDA review its approval processes for all Class III medical devices (i.e. those [MORE]
Abbott’s i-STAT handheld blood analyzer has just received an FDA waiver for five more tests using its 18 cartridges, which [MORE]
Stent
There are currently only four drug-eluting stents under FDA approval, and their effectiveness or ineffectiveness have been called into question. [MORE]
With a noticeable shift from small molecules to biologicals, it’s no surprise that The Philadelphia Business Journal reports that biopharma [MORE]